Articles Published in 2009

Covance Expands in Latin America

Tuesday, April 14, 2009 07:48 AM

Covance opened new clinical development offices in Santiago, Chile, and Lima, Peru, and expanded its office in Buenos Aires, Argentina, increasing the contract research organization (CRO)’s presence in Latin America.

More... »

RPS on Global Acquisition Spree

Monday, April 13, 2009 08:00 AM

ReSearch Pharmaceutical Services’ (RPS) plan to acquire a small contract research organization (CRO) in China will expand the company’s capabilities in Asia, but the deal is also part of a larger plan to expand RPS throughout the world by multiple acquisitions.

More... »

CenterWatch Monthly April 2009

Friday, April 10, 2009 08:00 AM

Pfizer’s Enhanced Clinical Trial Design Saves $100 Million Annually

More... »

US Oncology Launches CRO

Wednesday, April 8, 2009 08:00 AM

Cancer treatment and research network US Oncology has established a contract research organization (CRO), formalizing many of the CRO services that the organization already provided.

More... »

Pfizer is First Pharma Company to Receive AAHRPP Accreditation

Tuesday, April 7, 2009 08:00 AM

Pfizer is the first pharmaceutical company to be accredited by the Association for the Accreditation of Human Research Protection Programs. Pfizer (and its phase I clinical research units) was among 16 organizations to receive accreditation this quarter, bringing the total number of AAHRPP-accredited organizations to 175.

More... »

PPD Acquires Magen BioSciences, Plans to Sell Piedmont Research

Friday, April 3, 2009 02:00 PM

PPD acquired Magen BioSciences, a dermatology-focused biotechnology company—just as the contract research organization (CRO) announced plans to divest its preclinical research subsidiary Piedmont Research Center.

More... »

RPS to Acquire Paramax for $1M

Thursday, April 2, 2009 04:00 PM

ReSearch Pharmaceutical Services (RPS) has entered into an agreement to acquire Chinese contract research organization (CRO) Paramax International for $1 million in cash and 530,973 shares of RPS common stock.

More... »

Averion’s 2008 Revenues Up 90%, Net Loss Increases by $33.5M

Thursday, April 2, 2009 08:00 AM

Full-year 2008 revenues for oncology CRO Averion increased 90% over 2007, thanks in large part to an increase in European activity and the October 2007 acquisition of Hesperion, a clinical research organization based in Switzerland. Net service revenues in 2008 were $66.4 million, compared with $34.9 million in 2007.

More... »

New CenterWatch Report Examines Japan’s Surging Clinical Trials Market

Wednesday, April 1, 2009 03:00 PM

In 2007, drug development in Japan, the world’s second largest pharmaceutical market, exploded six-fold over 2006 and should continue to grow, according to a new CenterWatch report released today.

More... »

PMDA’s New Five-Year Plan Under Way Today

Wednesday, April 1, 2009 08:00 AM

Japan’s regulatory authority, Pharmaceuticals and Medical Devices Agency (PMDA), is launching several new initiatives in fiscal year 2009, which begins today. PMDA representatives were out in force at the DIA EuroMeeting in Berlin last week to explain the new programs, which will be implemented between fiscal year 2009 and fiscal year 2013.

More... »